India Drug Index app analytics for October 30

Description: India Drug Index is a comprehensive information resource on drugs approved for use in India. The app extensively covers over 4500+ drug entries, including the newly FDA-approved small molecules and 80000+ brands marketed and prescribed all over India. * Easy to use quick drug reference available * Free drug database provides complete information about the drugs and its pricing * Helps in making better treatment and decision making * Completely evidence based with 500,000+ references * Prepared by a team of 15 editors, which includes Top Physicians and Pharmacologists * Based on the latest guidelines and PI App Features: 1) You can search drug molecules for the complete prescribing and pricing information in detail. The information provided are incorporated from standard references or PI modules. 2) Enhanced with advanced searching ability to find individual or combination brands available in Indian markets. The latest pricing and company information is also listed side by side. You can find alternative or brand substitutes using our unique tool. You can also filter out the most popular brands prescribed in the country, sort according to brand prices etc. 3) Updating: We update as per the new guidelines and policies on a regular day to day basis. 4) The drug database has the "full offline” option. You can choose to download the entire library offline for easy access. Once when you downloaded the app it does periodic updates in the background. Update Policy: Every day our internal search engine crawls 500+ publications to identify changes in dose, adverse effects and practice insights. New molecules approved by the FDA are added within 24 hours. Reference: India Drug Index prescription drug monographs are based on FDA or its international counterparts approved labeling information unless otherwise noted, combined with additional data derived from primary medical literature. Our comprehensive drug information database is based on (but not limited to) following sources: Database / Organization Link * USFDA Drug Information Database (Drugs@FDA) - https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm * Central Drugs Standard Control Organization (CDSCO) - https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/ * National Library of Medicine (NLM) Database (PubMed) - https://www.nlm.nih.gov/pubs/techbull/mj26/mj26_issue_cover.html * European Medicines Agency (EMA) Medicines Database (EudraPharm) - https://www.ema.europa.eu/en/medicines * ACOG Guidelines (American College of Obstetricians and Gynecologists) - https://www.acog.org/clinical * NICE Guidance (National Institute for Health and Care Excellence) - https://www.nice.org.uk/guidance * National Portal of India – Online Drug Information - https://www.india.gov.in/category/health-wellness * Clinical Information Canada (Drug Product Database) - https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html * Centers for Disease Control and Prevention (CDC) - https://www.cdc.gov/ * World Health Organization (WHO) Publications - https://iris.who.int/ * AIOCD AWACS Database - https://www.aiocdawacs.com/ProductDetail.aspx Disclaimer: The information is published based upon publicly available sources generally viewed as reliable in the healthcare community. All information contained in the application is provided for educational purposes only. This information is not intended to replace clinical judgment or guide individual patient care in any manner. This information should not be used for the diagnosis or treatment of any health problem or disease. Neither India Drug Index nor any other party involved in the preparation, publication, or distribution of the system shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any User's use of or reliance upon this system and the information contained within.